Trial Profile
A clinical study of apatinib and cisplatin with concurrent radiotherapy for treatment of cervical cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2018
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Rivoceranib (Primary)
- Indications Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
- 01 Jun 2018 New trial record